Login
Toggle navigation
Videos
Categories
Trending
Entrevista com Rogério Jorge, CEO da AES Brasil, com foco na geração de energia no Brasil.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Rogério Jorge. President of AES Brasil
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
ISG Presentation at NobleCon17: Driving Global Technology Transformation | Michael P. Connors - Chairman & CEO of Information Services Group, Inc.
00:10:00
"Kjell Morten Johnsen is the CEO of Tele2."
00:10:00
Red Paramount Iron CEO Discusses Green Iron Production and Community Engagement
00:10:00
Fund established by operators for operators|Arielle Zuckerberg,General Partner,Long Journey Ventures
00:10:00
Aurumin Limited: Company Overview and Gold Projects Presentation
00:10:00
Identifying Value in Today's Global Credit Markets: Insights Live with Oaktree's Leading Experts
00:10:00
Mod Resources: Dominating Botswana's Copper Belt with Expansive Exploration Opportunities
00:10:00
Launching Mobile Backgammon Game with Real-Time Voice and Video Integration Aims to Boost User Engagement and Subscriptions | Jason Katz, CEO, Paltalk Inc.
00:10:00
Mr. Joseph Bugeja, Chairman and CEO of Transport Malta, discusses a metro system proposal in a public interview.
00:10:00
Creating Vibrant Urban Destinations: CEO Discusses Future Workplaces and Brewery Project Transformation | Nicklas Lindberg, CEO, Echo Investment SA.
00:10:00
Understanding 409A Valuations: Key Insights for Employee Stock Compensation | Mark Dempster, Co-Founder, Founders Circle Capital.
00:10:00
Data#3 & Cisco's Award-Winning Partnership | Brad Colledge, CEO, Data#3 LtdDTL:ASX